Weather and sea conditions could delay crews getting to the Longships Lighthouse to do the repair - Matt Cardy/Getty Images A faulty lighthouse foghorn has been keeping people awake for almost a week ...
As of Thursday, December 18, Foghorn Therapeutics Inc.’s FHTX share price has surged by 7.50%, which has investors ...
Foghorn Therapeutics has finally given up on its only wholly owned clinical-stage candidate after the troubled cancer drug came up short in a phase 1 study in patients with acute myeloid leukemia (AML ...
Fintel reports that on December 18, 2025, BTIG initiated coverage of Foghorn Therapeutics (NasdaqGM:FHTX) with a Buy recommendation. Analyst Price Forecast Suggests 139.93% Upside As of December 6, ...
TipRanks on MSN
Foghorn Therapeutics initiated with a buy at BTIG
BTIG initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $11 price target The firm says Foghorn is a clinical-stage biopharmaceutical company developing novel inhibitors and ...
As Foghorn Therapeutics battles to free a trial from an FDA clinical hold, the biotech is now facing a partial hold for another program—meaning the company's two clinical assets are now tied up in red ...
A patient has died in a clinical trial testing a Foghorn Therapeutics drug candidate for blood cancer, leading the FDA to pause enrollment of new patients in the study. Circumstances of the death are ...
The foghorn at the South Breakwater Light station, on the ship canal, was quite a presence in Duluth when I was a very little girl. My earliest memory of it, however, was not until just before I ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--FogHorn, a leading developer of edge computing AI software for industrial and commercial Internet of Things (IoT) solutions, today announced plans to collaborate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback